Dr Pedro López-Romero, a senior research scientist from Lilly, and Dr Eugen Feist from the Charité. Join Prof Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, they discuss anti-CarbV and anti-MCV titres as predictors for improvements in SDAI score and radiographic progression in patients with RA.
